Celyad Oncology SA (EBR:CYAD)
Belgium · Delayed Price · Currency is EUR 0.3110
-0.0080 (-2.51%)
Apr 30, 2026, 4:00 PM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €13.92 million as of May 1, 2026. Its market cap has decreased by -30.43% in one year.
Market Cap
13.92M
Enterprise Value
12.21M
Revenue
21.00K
Ranking
n/a
PE Ratio
17.28
Stock Price
€0.31
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 13.92M, a decrease of -86.35%. That is a compound annual growth rate of -14.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 13.92M | 82.94% |
| Dec 31, 2025 | 7.61M | -74.20% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 44.01B |
| argenx SE | 41.54B |
| Financière de Tubize | 8.71B |
| Onward Medical | 184.95M |
| Hyloris Pharmaceuticals | 135.80M |
| European Medical Solutions | 22.22M |
| BioSenic | 1.44M |
| Oxurion NV | 337.03K |